SUPN — Supernus Pharmaceuticals, Inc. stock price, charts and financials

QT40Supernus Pharmaceuticals, Inc.

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
43.25
-2.75-5.98%
OverviewShort InterestFilings
SUPNQT40Supernus Pharmaceuticals, Inc.·NASDAQ
43.25-5.98%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Aug 04, 2026425Prospectus / business-combination communication
Aug 03, 20268-KCurrent report
Aug 03, 20268-KCurrent report
Aug 03, 20268-KCurrent report
Aug 03, 2026DEFA14AAdditional proxy soliciting materials
Aug 03, 2026425Prospectus / business-combination communication
Aug 03, 2026425Prospectus / business-combination communication
Aug 03, 202610-QQuarterly report
Aug 03, 2026425Prospectus / business-combination communication
Aug 03, 20268-KCurrent report
Aug 03, 2026DEFA14AAdditional proxy soliciting materials
Aug 03, 2026425Prospectus / business-combination communication
Aug 03, 2026DEFA14AAdditional proxy soliciting materials
Jul 31, 20264Statement of changes in beneficial ownership
Jul 31, 20264Statement of changes in beneficial ownership
Jul 31, 20264Statement of changes in beneficial ownership
Jul 31, 20264Statement of changes in beneficial ownership
Jul 31, 20264Statement of changes in beneficial ownership
Jul 22, 20268-KCurrent report
Jun 22, 2026S-8Registration of employee benefit securities
Jun 18, 20268-KCurrent report
May 20, 20268-KCurrent report
May 05, 20268-KCurrent report
May 05, 202610-QQuarterly report
Apr 30, 2026DEF 14ADefinitive proxy statement
#1 / 25 of 461
Page
▼
/ 19